Phase I study of cisplatin (cDDP)/hyperthermia (HT)/lapatinib (Lap) in patients (pts) with recurrent carcinoma of the uterine cervix (rCC) in previously irradiated area (PIA).
Esther Van Meerten
No relevant relationships to disclose
A.M. Westermann
No relevant relationships to disclose
H. C. van Doorn
No relevant relationships to disclose
Martine Franckena
No relevant relationships to disclose
Jaco Kraan
No relevant relationships to disclose
Erik A.C. Wiemer
No relevant relationships to disclose
Stefan Sleijfer
No relevant relationships to disclose